CYR61
CYR61 (CCN1)[edit]

CYR61, also known as CCN1, is a matricellular protein that plays a crucial role in cell signaling, development, and repair processes. It is a member of the CCN family of proteins, which are involved in various cellular functions including cell adhesion, migration, proliferation, and differentiation.
Structure[edit]
CYR61 is characterized by its modular structure, which includes several distinct domains that contribute to its diverse biological functions. The protein consists of the following domains:
- An insulin-like growth factor binding protein (IGFBP) domain
- A von Willebrand factor type C (vWC) domain
- A thrombospondin type 1 (TSP1) repeat
- A cysteine knot (CT) domain
These domains allow CYR61 to interact with a variety of cell surface receptors, extracellular matrix components, and growth factors.
Function[edit]
CYR61 is involved in numerous physiological processes, including:
- Angiogenesis: CYR61 promotes the formation of new blood vessels by stimulating endothelial cell proliferation and migration.
- Wound healing: It plays a role in tissue repair by modulating the activity of fibroblasts and other cell types involved in the healing process.
- Development: CYR61 is essential for normal embryonic development, particularly in the formation of the cardiovascular system and skeletal system.
Clinical Significance[edit]
Alterations in CYR61 expression have been associated with various pathological conditions, including:
- Cancer: Overexpression of CYR61 has been observed in several types of cancer, where it may contribute to tumor growth and metastasis.
- Fibrosis: Dysregulation of CYR61 is implicated in fibrotic diseases, where excessive tissue scarring occurs.
- Inflammation: CYR61 can modulate inflammatory responses, influencing the progression of inflammatory diseases.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian